Your browser doesn't support javascript.
loading
Factors associated with depression in patients with Parkinson's disease: a multicenter study in Lima, Peru / Fatores associados à depressão em pacientes com doença de Parkinson: um estudo multicêntrico em Lima, Peru
Custodio, Nilton; Alva-Diaz, Carlos; Morán-Mariños, Cristian; Mejía-Rojas, Koni; Lira, David; Montesinos, Rosa; Herrera-Pérez, Eder; Castro-Suárez, Sheila; Bardales, Yadira.
  • Custodio, Nilton; Peruvian Institute of Neurosciences. Department of Neurology. Lima. PE
  • Alva-Diaz, Carlos; Peruvian Institute of Neurosciences. Research Unit. Lima. PE
  • Morán-Mariños, Cristian; Peruvian Institute of Neurosciences. Research Unit. Lima. PE
  • Mejía-Rojas, Koni; Peruvian Institute of Neurosciences. Research Unit. Lima. PE
  • Lira, David; Peruvian Institute of Neurosciences. Department of Neurology. Lima. PE
  • Montesinos, Rosa; International Clinic. Diagnostic Unit for Cognitive Impairment and Dementia Prevention. Lima. PE
  • Herrera-Pérez, Eder; International Clinic. Diagnostic Unit for Cognitive Impairment and Dementia Prevention. Lima. PE
  • Castro-Suárez, Sheila; Peruvian Institute of Neurosciences. Department of Neurology. Lima. PE
  • Bardales, Yadira; International Clinic. Diagnostic Unit for Cognitive Impairment and Dementia Prevention. Lima. PE
Dement. neuropsychol ; 12(3): 292-298, July-Sept. 2018. tab
Article in English | LILACS | ID: biblio-952969
ABSTRACT
Abstract The diagnosis and treatment of depression in patients with Parkinson's disease (PD) is inadequate, often contributing to a reduced quality of life, rapid disease progression, higher cognitive impairment, and an increased burden of care for family members of patients with PD.

Objective:

To determine the factors associated with depression in PD and to examine the frequency of depressive symptoms among patients with PD.

Methods:

This study was an observational, analytical, multicenter study of a cross-sectional cohort, conducted between July 2016 and May 2017. PD patients were recruited from neurology clinics in Lima, Peru. All statistical analyses were performed using descriptive statistics. Bivariate and multivariate logistic regression analyses were calculated using STATA.

Results:

Out of 124 patients (average age 68.7 years; 58% males) included in the study 60.5% (75/124) presented with symptoms of depression; only 20% (25/124) received antidepressants. Factors associated with depression in PD included unemployment, falls, freezing of gait, involuntary movements micrographia, stooped posture, hyposmia, movement disorders in sleep, rapid disease progression, and the use of MAOIs. Furthermore, statistically significant differences were found in disease duration, UPDRS and MMSE scores, Hoehn and Yahr (HY) stage, and length of time taking L-dopa between PD patients with and without depressive symptoms.

Conclusion:

Factors associated with depressive symptoms in patients with PD were hyposmia, rapid progression of the disease, the use of L-dopa, and use of MAOIs. The frequency of depressive symptoms in patients with PD is high; early diagnosis and prompt treatment are needed to improve their quality of life and the family environment.
RESUMO
Resumo O diagnóstico e tratamento da depressão em pacientes com doença de Parkinson (DP) é inadequado, frequentemente contribuindo para a redução da qualidade de vida, progressão rápida da doença, maior comprometimento cognitivo e aumento da carga de cuidado aos familiares de pacientes com DP.

Objetivo:

Determinar os fatores associados à depressão na DP e examinar a frequência de sintomas depressivos entre pacientes com DP.

Métodos:

Este estudo foi um estudo observacional, analítico, multicêntrico, de uma coorte transversal conduzida entre julho de 2016 e maio de 2017. Os pacientes com DP foram recrutados em clínicas de neurologia em Lima, Peru. Todas as análises estatísticas foram realizadas por meio de estatística descritiva. Análises de regressão logística bivariada e multivariada foram calculadas usando STATA.

Resultados:

Dos 124 pacientes (idade média 68,7 anos; 58% homens) incluídos no estudo, 60,5% (75/124) apresentaram sintomas de depressão; apenas 20% (25/124) receberam antidepressivos. Os fatores associados à depressão na DP incluíram desemprego, quedas, congelamento da marcha, movimentos involuntários micrografia, postura inclinada, hiposmia, distúrbios do movimento no sono, progressão rápida da doença e uso de inibidores da MAO. Além disso, houve diferenças estatisticamente significativas encontradas em duração da doença, escores nas escalas UPDRS e MMSE, estágio Hoehn e Yahr (HY) e tempo de duração da L-dopa entre os pacientes com DP, entre aqueles com e sem sintomas depressivos.

Conclusão:

Fatores associados a sintomas depressivos em pacientes com DP foram hiposmia, rápida progressão da doença, uso de L-dopa e uso de IMAOs. A frequência de sintomas depressivos em pacientes com DP é alta; o diagnóstico precoce e o tratamento imediato são necessários para melhorar a qualidade de vida e o ambiente familiar.
Subject(s)


Full text: Available Index: LILACS (Americas) Main subject: Parkinson Disease Type of study: Controlled clinical trial / Diagnostic study / Etiology study / Observational study / Risk factors / Screening study Limits: Humans Country/Region as subject: South America / Peru Language: English Journal: Dement. neuropsychol Journal subject: NEUROCIENCIAS / Neurology / Psychology / Psychiatry Year: 2018 Type: Article Affiliation country: Peru Institution/Affiliation country: International Clinic/PE / Peruvian Institute of Neurosciences/PE

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Index: LILACS (Americas) Main subject: Parkinson Disease Type of study: Controlled clinical trial / Diagnostic study / Etiology study / Observational study / Risk factors / Screening study Limits: Humans Country/Region as subject: South America / Peru Language: English Journal: Dement. neuropsychol Journal subject: NEUROCIENCIAS / Neurology / Psychology / Psychiatry Year: 2018 Type: Article Affiliation country: Peru Institution/Affiliation country: International Clinic/PE / Peruvian Institute of Neurosciences/PE